Sign In
Buy SNN
$29.36
-0.120 (-0.407%)
At Close: Jun 02, 2026
Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting
08:00am, Monday, 12'th Feb 2024
12 February 2024 Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the premiere of its newly acquired CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant alongside the REG
Is Smith & Nephew SNATS (SNN) Stock Undervalued Right Now?
10:46am, Wednesday, 24'th Jan 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Australia's approach to musculoskeletal injury care and reimbursement demands rethink: Report
04:00pm, Sunday, 14'th Jan 2024
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces a new report examining musculoskeletal injury care and reimbursement in Australia that urges health payers and
Smith+Nephew closes acquisition of CartiHeal
03:09am, Wednesday, 10'th Jan 2024
Smith & Nephew PLC (LSE:SN) said today that it has closed the acquisition of CartiHeal, an Israel-based developer of sports medicine technology for cartilage regeneration in the knee. The medical
Smith & Nephew: Orthopedics Growth Continues To Drive Sales Forward
06:46am, Thursday, 28'th Dec 2023
Smith & Nephew shares are down 3.6% since February, but management has increased top-line growth guidance for fiscal 2022. The Orthopedics business unit is showing strong growth potential, with moment
Smith & Nephew (SNN) New Buyout Expands Sports Medicine Suite
12:47pm, Tuesday, 28'th Nov 2023
Smith & Nephew (SNN) will pay an initial cash consideration of $180 million at closure, with an additional $150 million based on financial performance to acquire CartiHeal.
Smith & Nephew acquires cartilage regeneration firm
03:13am, Wednesday, 22'nd Nov 2023
Smith & Nephew PLC (LSE:SN) has announced the acquisition of knee cartilage regeneration technology developer CartiHeal. Under the agreement, the FTSE 100-listed medical equipment manufacturer will p
Smith & Nephew's underperformance set to change, says Goldman
10:03am, Friday, 10'th Nov 2023
Smith & Nephew PLC (LSE:SN)'s underperformance is set to change, according to Goldman Sachs (NYSE:GS). The investment bank has initiated coverage of the medical technology outfit with a buy rating and
9 Once-In-A Lifetime Blue-Chip Opportunities Yielding As Much As 10%
07:10am, Tuesday, 07'th Nov 2023
For weeks, I have pounded the table about the historic opportunity in REITs. The fundamentals were clear that now was the best time in 14 years to buy REITs. Last week, stocks ripped 6% higher, and RE
Smith & Nephew plc (SNN) Q3 2023 Earnings Call Transcript
11:11am, Sunday, 05'th Nov 2023
Smith & Nephew plc (NYSE:SNN ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 AM ET Company Participants Deepak Nath - Chief Executive Officer Anne-Francoise Nesmes - Chief Financial Officer C
Smith & Nephew downgrade cycle coming to an end
06:24am, Friday, 03'rd Nov 2023
JPMorgan has upgraded the firm to overweight from neutral pointing out shares have de-rated to 10-year lows in recent weeks. This reflected concerns on a margin guidance downgrade post-H1 soft margins
Smith & Nephew shares up 4.2% on FY sales upgrade
04:43am, Thursday, 02'nd Nov 2023
Shares in Smith & Nephew PLC (LSE:SN) surged by 4.2% as the company projected sales growth to hit the upper end of its guidance following a robust third quarter, despite a slight tempering of margin g
Should Value Investors Buy Smith & Nephew SNATS (SNN) Stock?
11:16am, Friday, 29'th Sep 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Are Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now?
11:16am, Wednesday, 13'th Sep 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Smith & Nephew (SNN) Loses -5.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
11:17am, Monday, 04'th Sep 2023
Smith & Nephew (SNN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revi
